Drug & intervention

istradefylline

RxCUI 2199015

Clinical trials6
Recruiting0
Related conditions1
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

6 shown
Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease PatientsNCT00957203 · 2009-10-01
COMPLETED
Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking LevodopaNCT00955526 · 2009-07-01
COMPLETED
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaNCT00455507 · 2007-03-01
COMPLETED
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001NCT00199381 · 2005-10-01
TERMINATED
Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on LevodopaNCT00203957 · 2005-03-01
COMPLETED
A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa TherapyNCT00955045 · 2002-08-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.